Versigent Reports Third-Quarter 2026 Results and Updates Full-Year Guidance
Net sales were $2.45 billion, up 7.2% year over year, and adjusted EBITDA was $275 million, up 10.9%, at an 11.2% margin. Net income was $102 million versus $109 million a year earlier. Versigent projects 2026 net sales of $9.5 billion–$9.6 billion, adjusted EBITDA of $970 million–$1.01 billion and free cash flow of $275 million–$325 million.
Versigent PLC announced its third quarter 2026 financial results, reporting net sales of $2.45 billion, which represents a 7.2% increase compared to the same period in 2025. The company achieved an Adjusted EBITDA of $275 million, up 10.9% year-over-year, with an 11.2% margin. Net income for the quarter was $102 million, compared to $109 million in the prior-year quarter, impacted by higher interest expenses. Additionally, the company updated its full-year 2026 guidance, projecting net sales between $9.5 billion and $9.6 billion, Adjusted EBITDA between $970 million and $1.01 billion, and Free Cash Flow between $275 million and $325 million.
The Board of Directors also declared a quarterly cash dividend of $0.13 per share.